"But no ones suggesting that to me now," the president said at the NATO summit on Thursday. His assurances come as pressure mounts for him to prove his cognitive fitness before the elections. Facing ...
H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G pTau 217 CSF assay for the fully automated LUMIPULSE® G immunoassay analyzers. Th ...
SAN FRANCISCO--(BUSINESS WIRE)--Invitae Corporation (NYSE:NVTA), a genetic information company, today announced that it has expanded its genetic testing offering with hundreds of additional genes and ...
There is now a blood test that can diagnose a rare neurometabolic condition known as Glut1 deficiency syndrome, or De Vivo disease. Glut1 deficiency syndrome is caused by a mutation in a gene called ...
The market opportunities lie in addressing the rising demand for precise diagnostics driven by an aging population and increasing neurodegenerative diseases. Advances in AI, portable diagnostics, and ...
President Biden said he undergoes “a full neurological test every day” in his first interview since his disastrous debate against Donald Trump last week — but revealed he would not undergo an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results